Researchers from the universities of Zurich, Yale and Harvard reveal the differences between the characteristics of the ...

VIENNA, Va., September 10, 2024--CEL-SCI to present new data for Multikine head & neck cancer immunotherapy at the European Society for Medical Oncology 2024 Congress.

Shanghai Henlius Biotech, Inc. (2696.HK) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending approval ...

Novartis' Pluvicto is expected to dominate the market for radioligand therapies for prostate cancer, with revenue projections soaring to $4.3B by 2030. Read more here.

Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...

Hello Health Rounds Readers! Today we feature two early studies that might turn out to be laying the groundwork for some ...

Breast cancer is one of the most-researched illnesses in the world. But some men suffering from the disease say they’re not able to benefit from new research and treatments.

In a recent transaction, Sheena Jonathan, Co-Founder of Natera, Inc. (NASDAQ: NTRA ), a leader in personalized genetic testing and diagnostics, sold a significant amount of company stock. The sales, ...

FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...

CFT1946 Is Well-Tolerated at All Dose Levels; No Dose-Limiting Toxicities CFT1946 Achieves Dose Proportional Pharmacokinetic Exposure; Successfully Degrades BRAF V600 Mutant Protein Early Evidence of ...

Israeli warplanes carried out their most intense strikes on southern Lebanon in nearly a year of war, heightening the conflict between Israel and Lebanese armed group Hezbollah amid calls for ...

India may impose additional tariffs worth $1.1 billion on EU products in response to the bloc's extended safeguard duties on steel imports. The list of items, primarily steel products, is being ...